Pfizer

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE182A01018
  • NSEID: PFIZER
  • BSEID: 500680
INR
4,999.00
-3.8 (-0.08%)
BSENSE

Dec 05

BSE+NSE Vol: 2.2 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 8.16% vs 4.06% in Sep 2024

stock-summary

Standalone Net Profit

Growth in half year ended Sep 2025 is 23.20% vs 27.45% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 19.96% vs 25.03% in Sep 2024

stock-summary

Interest

Growth in half year ended Sep 2025 is 27.79% vs -24.82% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has improved from Sep 2024

Compare Half Yearly Results Of Pfizer With
Markets Mojo
Figures in Cr
Standalone Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,245.39
793.00
452.39
57.05%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,245.39
793.00
452.39
57.05%
Raw Material Cost
158.69
149.00
9.69
6.50%
Purchase of Finished goods
345.55
90.00
255.55
283.94%
(Increase) / Decrease In Stocks
-65.06
-55.00
-10.06
-18.29%
Employee Cost
190.49
156.00
34.49
22.11%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
175.77
209.00
-33.23
-15.90%
Total Expenditure (Excl Depreciation)
805.44
549.00
256.44
46.71%
Operating Profit (PBDIT) excl Other Income
439.95
244.00
195.95
80.31%
Other Income
109.02
55.00
54.02
98.22%
Operating Profit (PBDIT)
548.97
299.00
249.97
83.60%
Interest
5.38
85.00
-79.62
-93.67%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
543.59
214.00
329.59
154.01%
Depreciation
28.69
91.00
-62.31
-68.47%
Profit Before Tax
514.90
123.00
391.90
318.62%
Tax
134.13
0.00
134.13
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
380.77
123.00
257.77
209.57%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
380.77
123.00
257.77
209.57%
Equity Capital
45.75
81.00
-35.25
-43.52%
Face Value
10.00
5.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
83.23
7.59
75.64
996.57%
Diluted Earnings per share
83.23
7.50
75.73
1,009.73%
Operating Profit Margin (Excl OI)
35.33%
30.77%
0.00
4.56%
Gross Profit Margin
43.65%
26.99%
0.00
16.66%
PAT Margin
30.57%
15.51%
0.00
15.06%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 1,245.39 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 8.16% vs 4.06% in Sep 2024

Half Yearly - Standalone Net Profit
Standalone Net Profit 380.77 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 23.20% vs 27.45% in Sep 2024

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 439.95 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 19.96% vs 25.03% in Sep 2024

Half Yearly - Interest
Interest 5.38 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 27.79% vs -24.82% in Sep 2024

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 35.33%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has improved from Sep 2024